MDM2 (S160) Peptide

p53 is the most commonly mutated gene in human cancer identified to date. Expression of p53 leads to inhibition of cell growth by preventing progression of cells from G1 to S phase of the cell cycle. Most importantly, p53 functions to cause arrest of cells in the G1 phase of the cell cycle following any exposure of cells to DNA-damaging agents. The MDM2 (murine double minute-2) protein was initially identified as an oncogene in a murine transformation system. MDM2 functions to bind p53 and block p53-mediated transactivation of cotransfected reporter constructs. The MDM2 gene is amplified in a high percentage of human sarcomas that retain wildtype p53 and tumor cells that overexpress MDM2 can tolerate high levels of p53 expression. These findings argue that MDM2 overexpression represents at least one mechanism by which p53 function can be abrogated during tumorigenesis.

Prices direct from Bioworld Technology, Inc.

Quick response times

Exclusive Biosave savings/discounts

SPECIFICATIONS

Catalog Number

BS1447P

Applications

BNI

Form

1 mg/ml in DI water.

Purity

Synthetic peptide MDM2 (S160). (Note: the amino acid sequence is proprietary). The purity is > 98%.

Swiss Prot

Q00987

Storage Temp

Store at 4 degree C short term. Aliquot and store at -20 degree C long term. Avoid freeze-thaw cycles.

Additional Info

This peptide can be used with studies using BS1447 MDM2 (S160) pAb.

Alternative Names

Double minute 2 protein; E3 ubiquitin-protein ligase Mdm2; Hdm 2; Hdm2; MDM 2; MDM2; Mdm2 transformed 3T3 cell double minute 2 p53 binding protein (mouse) binding protein 104 a; MDM2; MDM2BP; MDM2BP; Mouse Double Minute 2; Mouse Double Minute 2; MTBP; Murine Double Minute Chromosome 2; Oncoprotein Mdm2; p53 Binding Protein Mdm2; p53 Binding Protein Mdm2; p53-binding protein Mdm2; Ubiquitin protein ligase E3 Mdm2; Ubiquitin protein ligase E3 Mdm2;